CClaimWatch
Plaintiff counsel in 9 cases

R. Jason Richards

Aylstock, Witkin, Kreis & Overholtz, PLLC

Address of record
17 East Main Street, Suite 200, Ste 200, Pensacola, FL 32502, 850-202-1010
Email
JRichards@awkolaw.com
Phone
(850) 202-1010
Fax
Fax 850-916-7449

Contact details as filed with the court in the cases below.

9
Cases tracked
9 active · 0 settled
—
Plaintiff-side recovery
Disclosed settlement funds
—
Defense-side exposure
Resolved in settlements
0
Cases with values
of 9 tracked

Case history

Publicly tracked matters where this attorney is listed as counsel.

Plaintiff counselActive litigation — no settlement yet

L'Oreal Fraud Class Action

This is a proposed class action against L'Oreal USA, Inc. The docket indicates the case is categorized as 'Other Fraud,' suggesting allegations of deceptive or fraudulent practices related to consumer products. No further details are available from the filing, and these allegations are not proven.

Filed
April 15, 2025
Represents
Ellen Painter, Robert Hightower
Plaintiff counselActive litigation — no settlement yet

L'Oreal Consumer Fraud Class Action

This is a putative class action against L'Oreal USA, Inc. The nature of suit is 'Other Fraud,' suggesting allegations of fraudulent conduct, likely involving consumer products. The docket indicates transfer to the Southern District of New York to be related to other L'Oreal cases, but no specific product or conduct is described.

Filed
December 2, 2024
Represents
Ellen Painter, Robert Hightower
Plaintiff counselActive litigation — no settlement yet

Alchemme Fraud Class Action

This is a proposed class action against Alchemme, LLC. The complaint, filed by plaintiff Jamie Heermann, is classified under 'Other Fraud,' indicating fraud-related claims. The specific factual allegations are not detailed in the docket entry, but the case appears to involve claims that could affect ordinary consumers.

Filed
September 4, 2024
Represents
Jamie Heermann
Plaintiff counselActive litigation — no settlement yet

Harvard Drug Group Deceptive Practices Class Action

A proposed class action has been filed against The Harvard Drug Group LLC, apparently alleging violations of New York General Business Law § 349 for deceptive practices, along with negligence, strict liability, and unjust enrichment. According to the docket, the court recently granted a motion to dismiss in part, dismissing the Section 349 and unjust enrichment claims with prejudice and allowing limited amendment of the negligence and strict liability claims. These are allegations in a pending case, not proven facts.

Filed
August 16, 2024
Represents
Moussa Kouyate
Plaintiff counselActive litigation — no settlement yet

Alchemee Fraud Class Action

This is a proposed class action against Alchemee, LLC. The case is classified as 'Other Fraud,' and multiple individual plaintiffs are named. The specific allegations are not detailed in the provided docket text, but the lawsuit appears to involve fraud claims brought on behalf of a putative class.

Filed
August 14, 2024
Represents
Cole Scroggs, Jamie Heermann, Bianca Jackson
Plaintiff counselActive litigation — no settlement yet

RB Health (US) Consumer Fraud Class Action

A proposed class action against RB Health (US) LLC, apparently concerning fraud allegations, as indicated by the nature of suit code for other fraud. Specific factual allegations are not available from the docket metadata.

Filed
August 14, 2024
Represents
Jamie Heermann
Plaintiff counselActive litigation — no settlement yet

Padagis Pharmaceuticals Product Liability Class Action

A proposed class action against Padagis Israel Pharmaceuticals Limited, apparently concerning product liability and contract claims over a pharmaceutical product. The specific product or alleged defect is not stated in the docket metadata.

Filed
April 4, 2024
Represents
Lindsey Daugherty, Tuan Nguyen, Cole Scroggs, Jarad Linn
Plaintiff counselActive litigation — no settlement yet

Crown Laboratories BPO Sales and Marketing Class Action

A proposed class action against Crown Laboratories, Inc. apparently concerning the sales and marketing of BPO products. The filings reference a consolidated amended class action complaint with numerous individual plaintiffs, alleging fraud in connection with the products. The case is in the Northern District of California and is proceeding on a motion to dismiss.

Filed
March 8, 2024
Represents
Priscilla Garcia, Chinyere Harris, William Eisman, Noemi Gerena, Marlena Timins, Michael Taylor, Emily Tam, Lorrie Potter, Shannon Citrino, Brett Gooden, Trakiia Pierce, Morgan Cratty, Abdallah Al-Qudsi, Marilyn Saavedra, Michelle Hollins, Jennifer Irizarry, Caitlyn Sheehan, Christina Stone, Latifah Abednego, Tiffany Snadowsky, Karen Hattley, Destiny Jensen, Joseph Diamond, Aaron Corcoran, Erica Millbank, Lisa Lavarone, Scott Linman, Kayleigh Schneider, Leanne Campbell, Kristen Davis, Angelina Flores, Holly Grossenbacher, Erin Del Toro, Louisa Romo
Plaintiff counselActive litigation — no settlement yet

Oral Phenylephrine Marketing Class Action

A proposed class action concerning marketing and sales practices for oral phenylephrine products, apparently alleging that defendants made false or misleading claims about the products. The case was recently filed and these are allegations, not proven facts.

Filed
December 6, 2023
Represents
Kaycie Coppock, Steve Audelo, Krystal Rampalli

“Recovery” and “exposure” refer to total disclosed settlement funds in associated cases, not money personally won or lost by an attorney. Settlements generally resolve disputed allegations without a finding that either side won. Data comes from public court dockets and may be incomplete.